View the top 5 stories to watch (6 June to 12 June) and our key company earnings schedule.

Is Sainsbury's takeover in the bag?

As well as the latest quarterly numbers from Sainsbury's (Wed) and Argos-owner Home Retail Group (Thu), we could expect an update over a potential investigation by the Competition and Markets Authority into the supermarket's takeover bid. Could this undermine the prospect of a quick resolution?

4 other events to look out for this week

1.    TUE 7 JUNE
No surprises expected from the RBA​
The Reserve Bank of Australia is unlikely to reduce rates further after the recent cut to a record low of 1.75%, but could there be more cuts later this year based on China's performance?

2.    WED 8 JUNE
Can Chinese manufacturing alleviate GDP concerns?​
Will May's data reinforce beliefs about China's inability to hit its GDP target this year, following a sharp slide in imports and exports in April?

3.    WED 8 JUNE
Will UK manufacturing data disappoint again?    
UK manufacturing PMI slumped to a three-year low in April. May's manufacturing and industrial production data raises the prospect of the economy stagnating in Q2.

4.    THU 9 JUNE
Will a slowdown in London prices hit Bellway Homes?    
After Bellway Homes posted a 43% profit jump in its last trading update, a slowdown in the capital's house prices could affect the company's Q3 numbers.
 

Selected company earnings (6 June-10 June)

Monday 6 June Results
No major releases scheduled  
Tuesday 7 June Results
Carclo (UK) Full-year
HD Supply Holdings (US) Q1
iomart Group (UK) Full-year
RWS Holdings (UK) Half-year
Sepura (UK) Full-year
Wednesday 8 June Results
AO World (UK)  Full-year
CMC Markets (UK) Full-year
GB Group (UK) Full-year
J Sainsbury (UK) Q1
Workspace Group (UK)  Full-year
Thursday 9 June Results
Auto Trader Group (UK) Full-year
Flybe Group (UK) Full-year
H&R Block (US) Q4
Home Retail Group (UK) Q1
Mattress Firm Holdings (US) Q1
Wincanton (UK) Full-year
Friday 10 June Results
Fuller Smith & Turner (UK) Full-year
Tailored Brands (US) Q1
Valeant Pharmaceuticals International (US) Q1

Company announcements are subject to change. All the events listed above were correct at the time of writing.


CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.